Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001062993-25-007763
Filing Date
2025-04-22
Accepted
2025-04-22 14:39:02
Documents
1
Effectiveness Date
2025-04-22
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 9872
  Complete submission text file 0001062993-25-007763.txt   11053
Mailing Address MINUS 1 ENTRY, GROUND FLOOR OF BLDG B GUTWIRTH INDUSTRIAL PARK TECHNION CITY, HAIFA L3 3200003
Business Address MINUS 1 ENTRY, GROUND FLOOR OF BLDG B GUTWIRTH INDUSTRIAL PARK TECHNION CITY, HAIFA L3 3200003 972 52-4803034
NurExone Biologic Inc. (Filer) CIK: 0001995074 (see all company filings)

EIN.: 000000000 | State of Incorp.: A0 | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-544231 | Film No.: 25857170